Clinical Trials Directory

Trials / Completed

CompletedNCT02965833

CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers

Clinical Study of CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
126 (actual)
Sponsor
Alcon, a Novartis Company · Industry
Sex
All
Age
45 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate CLEAR CARE® PLUS (CCP) compared to non-HYDRAGLYDE® multi-purpose contact lens solutions in presbyopes currently wearing soft contact lenses and experiencing symptoms of dryness.

Conditions

Interventions

TypeNameDescription
DEVICE3% hydrogen peroxide solution with HydraGlyde® Moisture MatrixFor cleaning, disinfection and overnight storage of contact lenses
DEVICEHabitual Multi-Purpose Contact Lens Solution
DEVICEHabitual Contact LensesParticipant's habitual contact lens brand worn in a daily wear modality for 30 days.

Timeline

Start date
2016-12-13
Primary completion
2017-03-24
Completion
2017-03-24
First posted
2016-11-17
Last updated
2018-07-11
Results posted
2018-04-26

Source: ClinicalTrials.gov record NCT02965833. Inclusion in this directory is not an endorsement.